Enlarged prostate (BPH): the slow squeeze on a middle-aged bladder
Last updated September 3, 2026.
Benign prostatic hyperplasia (BPH) is the non-cancerous enlargement of the prostate that most men develop with age, squeezing the urethra and slowing the plumbing: weak stream, hesitancy, dribbling, incomplete emptying, and night-time trips. It is not cancer and does not raise cancer risk (though the symptoms overlap enough to deserve proper assessment). Treatment scales from habit changes through tablets to genuinely effective day-case surgery.
What does it feel like?
The storage-and-flow pattern: a stream that is slow to start, weak, and stop-start; dribbling at the end; the sense the bladder never quite empties; needing to go again soon after; urgency (needing to go NOW, occasionally leaking on the way); and nocturia (the night trips, one becoming two becoming four). Symptoms creep over years, and men normalize astonishing amounts of inconvenience before mentioning it. The score that matters is bother: the same stream that one man ignores rules another man's life.
Why does it happen?
The prostate grows throughout adult life under hormonal influence (testosterone converted to DHT locally drives it), and from middle age the growing central zone progressively compresses the urethra. It is near-universal with age: most men over 50 have some enlargement, and bother rises each decade. Family history and metabolic factors (obesity, diabetes) nudge it along. It is benign tissue doing what aging prostates do, and its symptoms track obstruction plus an overactive bladder reacting to years of pushing.
What actually helps?
- Habit changes first: evening fluid reduction, cutting caffeine and alcohol (both irritate and fill), double voiding (go, wait, go again), and bladder training for the urgency.
- Alpha-blockers (tamsulosin and family): relax the prostate and bladder-neck muscle within days; the usual first medication.
- 5-alpha-reductase inhibitors (finasteride, dutasteride): shrink the gland itself over months, added for larger prostates; combination therapy beats either alone in big glands.
- Review your other medications: decongestants, antihistamines, and some antidepressants worsen flow; diuretics timed badly worsen the nights.
- Surgery when tablets fail: TURP (the classic, effective), and newer day-case options (UroLift, steam ablation, laser, aquablation) with faster recovery and better ejaculation preservation: the menu has genuinely improved.
When is it an emergency?
The prostate emergency is retention: being unable to pass urine at all, with a painful, swelling bladder, is a same-day emergency (it needs catheterization, and it is often triggered by decongestants, alcohol, or holding on too long). Also urgent: fever with urinary symptoms (infection in an obstructed system), visible blood in the urine, new back pain with leg weakness (not prostate: spinal emergency), and leaking with overflow. The slow stuff (worse stream, more night trips) is routine review, and worth mentioning precisely because men wait years. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Does an enlarged prostate mean prostate cancer?
No, and the distinction matters: BPH is benign overgrowth of the prostate's central zone, it does not turn into cancer, and it does not raise cancer risk; prostate cancer is a separate disease usually starting in the outer zone, often with no symptoms at all. The confusion is understandable because both are common in the same age group and the urinary symptoms overlap, which is why the assessment (examination and the PSA blood test, with its known limitations discussed honestly) screens both questions at once. Having BPH surgery does not protect against later cancer, and a normal-feeling prostate does not exclude one: the two simply coexist in the same organ.
What will the PSA test actually tell me?
PSA is a prostate-activity marker, not a cancer test: BPH itself raises it (bigger glands make more PSA), as do infection, recent ejaculation, cycling, and even a vigorous rectal exam, while cancer raises it too, so an elevated result starts a conversation (repeat testing, MRI, referral) rather than concluding anything. The honest framing to have before the blood draw: PSA screening reduces advanced-cancer diagnoses but also finds slow cancers that would never have harmed, leading some men into treatment they did not need; deciding whether to have it is a legitimate personal choice, which is why guidelines say discuss, then decide. For BPH management specifically, the PSA level also predicts gland growth and guides which medication combination makes sense.
Do the tablets work, and what are the side effects?
Two families, different jobs: alpha-blockers (tamsulosin, alfuzosin) relax the muscle in the prostate and bladder neck, improving flow within days to weeks, with side effects of dizziness on standing (take at bedtime), and, specifically with tamsulosin, reduced or retrograde ejaculation (orgasm with little or no fluid: harmless but startling if unmentioned). 5-alpha-reductase inhibitors (finasteride, dutasteride) shrink the gland by a fifth to a quarter over six-plus months, suiting bigger prostates, with small risks of libido drop and erectile effects. In larger glands the combination outperforms either alone. Most men get meaningful relief from tablets; the ones who do not move to the surgical menu.
What are the surgery options, and what has changed?
The menu has modernized: TURP (shaving the obstructing tissue from inside, under anesthesia) remains the reference standard with decades of evidence, effective but with a hospital stay and retrograde ejaculation in most; the newer day-case procedures trade some durability for convenience and sexual-side-effect preservation: UroLift (implants pinning the lobes open), steam ablation (Rezum: steam injections killing the excess tissue), laser enucleation (HoLEP: thorough, durable, suited to big glands), and aquablation (robotic water-jet, precise). Choice depends on gland size, anatomy, and your priorities on recovery versus durability versus sexual function, a genuine discussion rather than a default. The days when surgery meant a week in hospital are largely over.
Why do I get up at night, and can anything fix that specifically?
Nocturia has several contributors and BPH is only one: the obstructed bladder empties poorly and refills to its (reduced) comfortable capacity sooner, but night-time trips also come from evening fluids, alcohol, caffeine, poor sleep itself (you wake, then notice the bladder), leg swelling redistributing fluid overnight, and sleep apnea (a genuinely common hidden cause worth mentioning to the GP). The targeted fixes: nothing to drink for two to three hours before bed, alcohol and caffeine out after mid-afternoon, legs-up time in the evening, double voiding at bedtime, and treating the sleep if it is broken. Alpha-blockers help the prostate component. If nocturia persists with an empty-feeling bladder, the cause is elsewhere.
What happens if I keep ignoring it?
The trajectory of untreated significant BPH: symptoms usually progress slowly (worse stream, more night trips, more urgency), and the risks that accumulate are real but slow: urinary tract infections in a bladder that never empties, bladder stones, acute retention (the painful cannot-pee emergency, often triggered by a decongestant or a big night out), and, over years, bladder muscle damage and, rarely, back-pressure on the kidneys. None of this is a reason for panic; it is the argument for the assessment you are now having, because the early tablet phase is where the easy wins live, and the men who end up catheters-and-emergency-surgery are disproportionately the ones who planned journeys around toilets for a decade first.